Renal Safety of Hydroxyethyl starch 130/0.42 After Cardiac Surgery: A Retrospective Cohort Analysis.

Benedict MorathAndreas D MeidJohannes RickmannJasmin SoethoffMarkus VerchMatthias KarckMarcin Zaradzki

Published in: Drug safety (2021)

This study showed no association between HES and the postoperative occurrence of acute kidney injury and thus further closes the evidence gap on HES safety in cardiac surgery patients. Although this was a retrospective cohort study, the results indicated that HES might be safely administered to cardiac surgery patients with regard to renal outcomes, especially if it was administered early and dosed appropriately.

Keyphrases

cardiac surgery
acute kidney injury
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
risk assessment
prognostic factors
type diabetes
skeletal muscle
patient reported outcomes
weight loss
glycemic control